INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

PRVAPrivia Health Group, Inc.

CIK 0001759655

EDGAR filingsOpen in network
Disclosed transactions16
Buys / sells0 / 6
Max Insider Score31
Connections4with evidence

PRVA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
22
MD
Mountcastle DavidEVP & Chief Financial Officer
PRVAPrivia Health Group, Inc.
Open-market sale · 10b5-1 plan
SELL$680K
24.7K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 8000 · Services-Health Services · Nov 4, 2026
  • ← Insider ofevidence
    Morris Matthew ShawnDirector · Jun 30, 2026
  • ← Insider ofevidence
    Mountcastle DavidEVP & Chief Financial Officer · Apr 6, 2026
  • ← Insider ofevidence
    Fargis Edward CEVP & General Counsel · Mar 12, 2026
14
MS
Morris Matthew ShawnDirector
PRVAPrivia Health Group, Inc.
Option exercise · 10b5-1 plan
M
$176K
88.1K sh
Jun 26, 2026
Jun 30, 2026
traded Jun 26, 2026
+4d
SEC FORM 4

Evidence

31
MS
Morris Matthew ShawnDirector
PRVAPrivia Health Group, Inc.
Open-market sale · 10b5-1 plan
SELL$2.23M
88.1K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

10
MS
Morris Matthew ShawnDirector
PRVAPrivia Health Group, Inc.
Option exercise · 10b5-1 plan
M$126K
63.2K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

23
MS
Morris Matthew ShawnDirector
PRVAPrivia Health Group, Inc.
Open-market sale · 10b5-1 plan
SELL$1.60M
63.2K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

0
MS
Morris Matthew ShawnDirector
PRVAPrivia Health Group, Inc.
Option exercise · 10b5-1 plan
M—
88.1K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

0
MS
Morris Matthew ShawnDirector
PRVAPrivia Health Group, Inc.
Option exercise · 10b5-1 plan
M—
63.2K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

0
MD
Mountcastle DavidEVP & Chief Financial Officer
PRVAPrivia Health Group, Inc.
Option exercise · 10b5-1 plan
M$34K
17.2K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

16
MD
Mountcastle DavidEVP & Chief Financial Officer
PRVAPrivia Health Group, Inc.
Open-market sale · 10b5-1 plan
SELL$433K
17.2K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

0
MD
Mountcastle DavidEVP & Chief Financial Officer
PRVAPrivia Health Group, Inc.
Option exercise · 10b5-1 plan
M—
5,962 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

0
MD
Mountcastle DavidEVP & Chief Financial Officer
PRVAPrivia Health Group, Inc.
Option exercise · 10b5-1 plan
M—
1,001 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

0
MD
Mountcastle DavidEVP & Chief Financial Officer
PRVAPrivia Health Group, Inc.
Option exercise · 10b5-1 plan
M—
1,336 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

0
MD
Mountcastle DavidEVP & Chief Financial Officer
PRVAPrivia Health Group, Inc.
Option exercise · 10b5-1 plan
M—
8,897 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

20
MD
Mountcastle DavidEVP & Chief Financial Officer
PRVAPrivia Health Group, Inc.
Open-market sale
SELL$77K
3,385 sh
May 11, 2026May 13, 2026
traded May 11, 2026
+2dSEC FORM 4

Evidence

24
MD
Mountcastle DavidEVP & Chief Financial Officer
PRVAPrivia Health Group, Inc.
Open-market sale
SELL$116K
5,566 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC FORM 4

Evidence

17
FC
Fargis Edward CEVP & General Counsel
PRVAPrivia Health Group, Inc.
Grant or award
A—
28.3K sh
Mar 10, 2026Mar 12, 2026
traded Mar 10, 2026
+2dSEC FORM 4

Evidence